Seastar Medical Hldg Corp (ICU)

$1.26 +0.00 (0.02%)
Market Cap 13.63M
Revenue (ttm) 140,000.00
Net Income (ttm) -24.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -17,735.71%
Debt to Equity Ratio 0.00
Volume 73,225
Avg Vol 188,040
Day's Range N/A - N/A
Shares Out 9.80M
Stochastic %K 55%
Beta -0.93
Analysts Strong Sell
Price Target $7.00

Latest News on ICU

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Apr 8, 2025, 8:05 AM EDT - 20 days ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 27, 2025, 4:05 PM EDT - 4 weeks ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 24, 2025, 5:30 PM EDT - 4 weeks ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 18, 2025, 8:45 AM EDT - 5 weeks ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Feb 3, 2025, 4:05 PM EST - 2 months ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 22, 2025, 7:30 AM EST - 3 months ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 13, 2025, 8:30 AM EST - 3 months ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Jan 8, 2025, 8:30 AM EST - 3 months ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 23, 2024, 7:00 AM EST - 4 months ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Dec 11, 2024, 6:30 AM EST - 4 months ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

Dec 4, 2024, 8:30 AM EST - 5 months ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Nov 26, 2024, 8:00 AM EST - 5 months ago

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

Nov 22, 2024, 8:30 AM EST - 5 months ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

Nov 15, 2024, 8:30 AM EST - 5 months ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 13, 2024, 5:05 PM EST - 5 months ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

Nov 1, 2024, 8:30 AM EDT - 6 months ago

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Oct 31, 2024, 8:30 AM EDT - 6 months ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Oct 25, 2024, 11:32 AM EDT - 6 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

Oct 25, 2024, 8:30 AM EDT - 6 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

Oct 22, 2024, 8:30 AM EDT - 6 months ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

Oct 18, 2024, 8:30 AM EDT - 6 months ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

Oct 15, 2024, 8:30 AM EDT - 6 months ago

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

Oct 9, 2024, 8:30 AM EDT - 7 months ago

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

Oct 8, 2024, 8:30 AM EDT - 7 months ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

Sep 25, 2024, 8:30 AM EDT - 7 months ago

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Regulations And Stockholders Are Invited To Help The Schall Law Firm

Sep 14, 2024, 11:00 AM EDT - 8 months ago

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Regulations And Stockholders Are Invited To Help The Schall Law Firm

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Sep 7, 2024, 11:00 AM EDT - 8 months ago

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Sep 5, 2024, 12:34 PM EDT - 8 months ago

ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 5, 2024, 11:00 AM EDT - 8 months ago

SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

Sep 5, 2024, 8:00 AM EDT - 8 months ago

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

The Schall Law Firm Is Seeking Investors To Join A Case Against SeaStar Medical Holding Corporation For Securities Fraud

Sep 4, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Is Seeking Investors To Join A Case Against SeaStar Medical Holding Corporation For Securities Fraud

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

Sep 4, 2024, 8:30 AM EDT - 8 months ago

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

SeaStar Medical Holding Corporation May Have Violated Securities Laws And Affected Shareholders Are Invited To Contact The Schall Law Firm

Sep 3, 2024, 11:00 AM EDT - 8 months ago

SeaStar Medical Holding Corporation May Have Violated Securities Laws And Affected Shareholders Are Invited To Contact The Schall Law Firm

The Schall Law Firm Wants Individuals With Losses In SeaStar Medical Holding Corporation To Reach Out About A Lawsuit For Fraud

Sep 2, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Wants Individuals With Losses In SeaStar Medical Holding Corporation To Reach Out About A Lawsuit For Fraud

SeaStar Medical Holding Corporation Is Being Sued For Potential Securities Fraud And Affected Investors Should Contact The Schall Law Firm

Sep 1, 2024, 11:00 AM EDT - 8 months ago

SeaStar Medical Holding Corporation Is Being Sued For Potential Securities Fraud And Affected Investors Should Contact The Schall Law Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar

Aug 31, 2024, 11:25 AM EDT - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar